Skip to content
Triangle logo TriangleGet started
← All settings

DISEASE & TREATMENT SETTING

Intraocular (Uveal) Melanoma

Source-derived catalogue. This is not a treatment recommendation or a personalised trial match.

Exact scope

Intraocular (Uveal) Melanoma

Source population
Not part of this definition
Disease extent
Not part of this definition
Treatment line
Not part of this definition
Stage
Not part of this definition
Resectability
Not part of this definition
Biomarkers, prior therapy and derivation
molecular
    prior therapy
      derivation status
      clinically-proposed
      derivation note
      Derived from NCI topic(s): Intraocular (Uveal) Melanoma. Strongest NCIt resolution: candidate. Entity-level scope; stage, biomarker and treatment line are not yet part of this definition.
      source wording
      Source null
      5 more-specific settings
      Hepzato Kit: unresectable Uveal melanoma with KIT stated without a specific alteration →Hepzato Kit: unresectable Uveal melanoma →KIMMTRAK: unresectable metastatic Uveal melanoma →metastatic Intraocular (Uveal) Melanoma →recurrent Intraocular (Uveal) Melanoma →

      Study evidence for this setting

      3 linked studies · Applicability is a draft source assessment, not a determination of your eligibility.

      NCT00445965 · Registry condition search · Scope: narrower

      Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer

      3 outcome links · 1 safety-group records · 0 quality-of-life measures

      →

      NCT03070392 · Source cited / selected · Scope: narrower

      Safety and Efficacy of IMCgp100 Versus Investigator Choice in Advanced Uveal Melanoma

      6 outcome links · 2 safety-group records · 3 quality-of-life measures

      →

      NCT03207347 · Registry condition search · Scope: narrower

      A Trial of Niraparib in BAP1 and Other DNA Damage Response (DDR) Deficient Neoplasms (UF-STO-ETI-001)

      5 outcome links · 2 safety-group records · 0 quality-of-life measures

      →
      Source relationships and population-mapping limitations
      bindings
      1. release id
        clinical-indications-draft-1
        disease state id
        ds-intraocular-uveal-melanoma
        binding id
        ncit-C7712
        source collection
        ncit-concept
        source key
        C7712
        source excerpt
        Source null
        match status
        candidate
        match note
        Resolution status: candidate.
        recorded at
        2026-09-10T00:00:00Z
      mappings

        Download this complete draft source relationship record →

        Preserved source evidence · Not medical advice